Skip to main content

Table 1 Clinical characteristics and microbiology culture results of included patients stratified by in-hospital mortality

From: Informing antimicrobial management in the context of COVID-19: understanding the longitudinal dynamics of C-reactive protein and procalcitonin

Category All patients (n = 237) Survived (n = 182) Died (n = 55) p-value
Median age in years (IQR) 67 (54–79) 66 (51–78) 69 (60–81) NS
Male 144 (60.8%) 105/144 (72.9%) 39/144 (27.1%) NS
Female 93 (39.2%) 77/93 (82.8%) 16/93 (17.2%)
Received level 2 or level 3 care 59 (24.8%) 34/182 (18.7%) 25/55 (45.5%)  < 0.0001
Median presenting day of illness (IQR) 7 (3–10) 7 (3–11) 7 (3–10) NS
Median length of stay in hospital in days (IQR) 9 (5–18) 8 (4–17) 10 (7–20) NS
Median CRP concentration on days 1–2 of admission   125 mg/L 241 mg/L  < 0.0001
Median PCT concentration on days 1–2 of admission   0.13 ng/mL 0.245 ng/mL NS
Bacterial cultures taken once or more times during admission from:  
Blood—203/237 (86%) patients sampled 14/203 (6.9%) positive 11 (6.0%) 3 (5.5%) NS
Urine—123/237 (52%) patients sampled 21/123 (17.1%) 18 (9.9%) 3 (5.5%) NS
Respiratory tract—62/237 (27%) patients sampled 24/62 (38.7%) 17 (9.3%) 7 (12.7%) NS
  1. A p-value threshold of > 0.05 was denoted as statistically insignificant (NS)